Patents Examined by Mina Haghighatian
  • Product and method for providing enrichment and facilitating expression of natural behaviors in pigs
    Patent number: 11129396
    Abstract: The present invention relates to a formulation that can be utilised to facilitate expression of natural behaviour in pigs, and in particular sows and weaners and a method which utilises the formulation for the same.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: September 28, 2021
    Assignee: AUSTRALASIAN PORK RESEARCH INSTITUTE LTD
    Inventors: Matthew John Callaghan, Robert John Van Barneveld
  • Chemically modified small molecules
    Patent number: 11129794
    Abstract: Methods of modifying the rate of systemic absorption of a drug administered to a subject by a pulmonary route, the method comprising covalently conjugating a hydrophilic polymer to a drug, wherein the drug has a half-life of elimination from the lung of less than about 180 minutes, to form a drug-polymer conjugate, wherein the drug-polymer conjugate has a net hydrophilic character and a weight average molecular weight of from about 50 to about 20,000 Daltons, and wherein the half-life of elimination from the lung of the drug-polymer conjugate is at least about 1.5-fold greater than the half-life of elimination from the lung of the drug, wherein the half-life of elimination from the lung is measured by bronchioalveolar lavage followed by assaying residual lung material.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: September 28, 2021
    Assignee: Nektar Therapeutics
    Inventors: C. Simone Jude-Fishburn, David Lechuga-Ballesteros, Tacey X. Viegas, Mei-Chang Kuo, Hema Gursahani, Chester Leach, Yuan Song
  • Annatto extracts for insect repellency, larvicidal activity and methods of use
    Patent number: 11116210
    Abstract: Health concerns of the vector-borne diseases, such as, yellow fever, malaria, dengue fever and general discomfort due to insect bites, has encouraged the development of insecticides to kill insects and insect repellents to keep insects away from treated human skin. Annatto extracts as a natural insect repellent and insecticide have many advantages over synthetic such as lower harmful side effects, low resistance, and more environmentally friendly. Annatto extracts containing ishwarane (C15) and geranyl-?-terpinene (C20) have strong mosquito repellency. Annatto extracts containing geranyl-?-terpinene (C20) and geranylgeraniol (C20) have strong larvicidal activity. Annatto extracts with approximately equal C15 and C20 composition have insect repellency, and annatto extracts with mainly C20 composition have larvicidal activity. Annatto extracts have synergistic effects with other natural extracts.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: September 14, 2021
    Assignee: AMERICAN RIVER NUTRITION, LLC
    Inventors: Barrie Tan, Jia Zhang
  • Transdermal formulation for the treatment of pain and/or inflammation
    Patent number: 11116730
    Abstract: Described herein are transdermal formulations of phytocannabinoids and methods of using the same in the treatment of pain and/or inflammation.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: September 14, 2021
    Assignee: NexZol Pharma, Inc.
    Inventors: Joseph M. Fracassi, Thomas J. Scarlata
  • Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation
    Patent number: 11116731
    Abstract: A method of treating Atrial Fibrillation or a pre-Atrial Fibrillation condition in a mammal, preferably a human, comprising administering a therapeutically effective amount of one of organic or inorganic sulfide, organic or inorganic nitrite, both organic or inorganic sulfide and organic or inorganic nitrite, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: September 14, 2021
    Assignee: Brd. of Sup. of LSU and A &M College
    Inventors: Christopher G. Kevil, Paari Dominic
  • Antimicrobial silver iodate
    Patent number: 11116865
    Abstract: The present invention is silver (I) periodate compounds and their use in preventing or reducing microbial contamination. The invention includes gels, coatings, and articles of manufacture having a surface contacted or coated with a gel comprising an antimicrobial silver (I) compound. Methods of treatment are also disclosed.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: September 14, 2021
    Assignee: Innovotech, Inc.
    Inventors: Merle E. Olson, Patricia L. Nadworny, Graeme Prosperi-Porta
  • Methods and materials for treating lung disorders
    Patent number: 11110131
    Abstract: This document provides methods and materials for treating lung conditions induced by inhalable insulin therapy. For example, compositions including a dried amnion tissue preparation and/or a dried stem cell preparation as well as methods for using such compositions to treat inhalable insulin induced lung conditions are provided.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: September 7, 2021
    Inventor: Gary M. Petrucci
  • Manufacture of pharmaceutical compositions
    Patent number: 11103448
    Abstract: The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: August 31, 2021
    Assignee: VECTURA LIMITED
    Inventors: David Morton, John Staniforth
  • Dry powder formulation of azole derivative for inhalation
    Patent number: 11103501
    Abstract: A spray dried-powder composition for inhalation comprising particles (X) containing (a) between 5 and 50% by weight of at least one azole derivative in amorphous state but not in crystalline structure and (b) at least one matricial agent to the composition selected from a group consisting of polyol such as sorbitol, mannitol and xylitol; a monosaccharides such as glucose and arabinose; disaccharide such as lactose, maltose, saccharose and dextrose; cholesterol, and any mixture thereof, wherein the composition provides a dissolution rate of said azole derivative of at least, 5% within 10 minutes, 10% within 20 minutes and 40% within 60 minutes when tested in the dissolution apparatus type 2 of the United States Pharmacopoeia at 50 rotation per minute, 37° C. in 900 milliliters of an aqueous dissolution medium adjusted at pH 1.2 and containing 0.3% of sodium laurylsulfate.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: August 31, 2021
    Inventors: Arthur Deboeck, Francis Vanderbist, Philippe Baudier, Thami Sebti, Christophe Duret, Karim Amighi
  • Protein-based film coatings and uses thereof
    Patent number: 11102976
    Abstract: Film coatings comprising protein and lipid, and methods of using the film coatings to coat biological surfaces. For example, when applied to the surface of plant seeds, the film coating adheres to and reinforces the outer seed coat or hull to maintain seed viability.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: August 31, 2021
    Assignee: 3 Star Ag LLC
    Inventor: Brian A. Tulley
  • Benzoxaborole compounds
    Patent number: 11064701
    Abstract: The present invention relates to the use of the compounds of formula (I) wherein the variables are defined according to the description, for controlling unwanted vegetation Further the invention relates to novel compounds of the formula (I), compositions comprising them a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one azine of the formula I to act on plants, their seed and/or their habitat.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: July 20, 2021
    Assignee: BASF SE
    Inventors: Matthias Witschel, Thomas Mietzner, Manuel Johannes, Thomas Seitz, Trevor William Newton, Gerd Kraemer, Stefan Tresch
  • Non-therapeutic method, uses of a substance that stimulates or generates an increase in volume
    Patent number: 11058623
    Abstract: The present invention aims to provide a non-surgical and non-therapeutic (cosmetic) method of dynamic three-dimensional facelift.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: July 13, 2021
    Inventor: Daniel Dal' Asta Coimbra
  • Polymeric coating compositions
    Patent number: 11044906
    Abstract: An emulsion polymer system suitable for use in agrochemical formulations for coating seeds. The emulsion polymer system comprises a core polymer and stabiliser polymer where the core is a polymer with a low glass transition temperature (?100° C. to 10° C.) and the stabiliser has a high glass transition temperature (30° C. to 300° C.). There is also provided a method of making the core-stabiliser system. The core-stabiliser system is suitable for seed coating formulations provided dust off, germination, and good flow.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: June 29, 2021
    Inventors: Howard Dungworth, James Wickson, Kathryn Knight, James Flavell
  • 4% trisodium citrate solution for use as a catheter lock solution
    Patent number: 11045589
    Abstract: Provided herein are catheter lock solutions having anticoagulation and antimicrobial properties, the catheter lock solutions including citrate salts. The citrate salt can be trisodium citrate, and the catheter lock solution can further include a diluted acid for adjusting the pH of the catheter lock solution.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: June 29, 2021
    Assignee: Becton, Dickinson and Company
    Inventors: Roza Mahmoodian, Suzanne Ferreri
  • Solid herbicide compositions containing fluroxypyr-meptyl
    Patent number: 11039614
    Abstract: The present disclosure concerns herbicide granules and powders containing a high-load of fluroxypyr-meptyl. The granules exhibit good storage stability and good herbicidal efficacy when added to water and applied by spray application to control unwanted plant growth.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: June 22, 2021
    Assignee: Corteva Agriscience LLC
    Inventors: Ashish Batra, David J. Adrian, Raymond E. Boucher, Jr., Joseph C. Hercamp, Hiteshkumar Dave, Hao Shen
  • Cyclopropene compositions
    Patent number: 11013231
    Abstract: Stabilized liquid cyclopropane compositions are provided which compromise flowable, non-aqueous dispersion concentrates comprising a) a continuous substantially water-immiscible liquid phase and b) a dispersed solid phase comprising cured polymer particles prepared from a polymerizable thermoset resin which particles contain at least one cylcopropene complex, optionally a non-porous particulate mineral, and optionally a non-cross-linkable mobile chemical distributed therein, and wherein the outside surfaces of the particles comprise a colloidal solid material. The compositions of the invention can be used directly or with dilution to combat pests or as plant growth regulators.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: May 25, 2021
    Assignee: SYNGENTA PARTICIPATIONS AG
    Inventors: Jeffrey David Fowler, Sejong Kim
  • Stable fat-soluble active ingredient composition, microcapsule and process of preparation and use thereof
    Patent number: 11013807
    Abstract: The present invention provides a stable fat-soluble active ingredient composition, microcapsule and process for preparation and use thereof. The fat-soluble active ingredient composition comprises tocopherol, vitamin C palmitate and a fat-soluble active ingredient; wherein the weight ratio of tocopherol to vitamin C palmitate is 2-8:1, the weight ratio of a combination of tocopherol with vitamin C palmitate to the fat-soluble active ingredient is 7-13:100. The present invention obtains a novel antioxidant composition without hidden dangers for improving the stability of the fat-soluble active ingredient by screening a combination of antioxidants and adjusting their proportion and dose.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: May 25, 2021
    Assignees: ZHEJIANG MEDICINE CO., LTD. XINCHANG PHARMACEUTICAL FACTORY, ZHEJIANG MEDICINE CO., LTD. VITAMIN FACTORY
    Inventors: Guoquan Mao, Hongming Zhu, Wenxin Ma, Zhiping Liang, Li Qian, Fritz Bernhard Lubbe, Siping Hu, Chun Li, Shanping Wen, Qinlan Wang, Huajuan Kong
  • Gastroretentive dosage forms for sustained drug delivery
    Patent number: 11007145
    Abstract: The present disclosure is directed to floating gastroretentive dosage forms with prolonged gastric residence time. The disclosure also provides rapidly expanding sustained release or combined immediate release and sustained release formulations comprising drugs that require targeted release in the proximal gastrointestinal tract for maximum therapeutic benefit. The rapidly expanding floating gastroretentive dosage forms comprise a permeable elastic membrane providing desired characteristics for drug release and mechanical strength to maintain tablet integrity.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: May 18, 2021
    Assignee: KASHIV SPECIALTY PHARMACEUTICALS, LLC
    Inventors: Kanji Meghpara, Jaydeep Vaghashiya, Navnit H. Shah, Dipen Desai, Wantanee Phuapradit, Harpreet Kaur Sandhu, Siva Ram Kiran Vaka, Namdev B. Shelke, Ashish Chatterji
  • Compositions and methods for ophthalmic and/or other applications
    Patent number: 10993908
    Abstract: Particles, compositions, and methods that aid particle transport in mucus are provided. The particles, compositions, and methods may be used, in some instances, for ophthalmic and/or other applications. In some embodiments, the compositions and methods may involve modifying the surface coatings of particles, such as particles of pharmaceutical agents that have a low aqueous solubility. Such compositions and methods can be used to achieve efficient transport of particles of pharmaceutical agents though mucus barriers in the body for a wide spectrum of applications, including drug delivery, imaging, and diagnostic applications. In certain embodiments, a pharmaceutical composition including such particles is well-suited for ophthalmic applications, and may be used for delivering pharmaceutical agents to the front of the eye and/or the back of the eye.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: May 4, 2021
    Assignee: The Johns Hopkins University
    Inventors: Alexey Popov, Elizabeth M. Enlow, Hongming Chen, James Bourassa
  • Aerosolized fluoroquinolones and uses thereof
    Patent number: 10987357
    Abstract: Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: April 27, 2021
    Assignee: Horizon Orphan, LLC
    Inventors: Mark W. Surber, Keith A. Bostian, Michael N. Dudley, Olga Rodny, David C. Griffith